Page last updated: 2024-10-28

1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Atrophy, Muscular, Peroneal

1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Atrophy, Muscular, Peroneal in 2 studies

1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanwal, S1
Perveen, S1
Nobbio, L1
Sturla, L1
Fiorese, F1
Usai, C1
Basile, G1
Moreschi, I1
Benvenuto, F1
Zocchi, E1
De Flora, A1
Schenone, A1
Bruzzone, S1

Other Studies

2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Atrophy, Muscular, Peroneal

ArticleYear
In-silico and Molecular Analysis of Reticulon 4asNovel therapeutic option for axonal regeneration.
    JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:10

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Axons; Charcot-Marie-Tooth Disease; Child, Pre

2019
P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy.
    The Journal of biological chemistry, 2009, Aug-21, Volume: 284, Issue:34

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Animals, Genetically Modified; Blotting, Wes

2009